RhumbLine Advisers’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

RhumbLine Advisers’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-27,158	Closed	-$1.69M	–	4290
2023 Q4	$1.69M	Buy	+27,158	New	+$675K	﹤0.01%	1992

RhumbLine Advisers's RYZB Position: Q1 2024 in Review

RhumbLine Advisers sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 27,158 shares — an estimated $1.69M sold.

RhumbLine Advisers first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $1.69M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

RhumbLine Advisers reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
RhumbLine Advisers sold 27,158 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $1.69M.
RhumbLine Advisers first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
RhumbLine Advisers's RayzeBio, Inc. Common Stock position peaked at $1.69M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.